Type 2 Diabetes Trial, Recruiting NCT06784375 Sponsor: University of Minnesota Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06784375
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are at least 18 years old
  • You have previously been diagnosed with type 2 diabetes
  • Your most recent HbA1c blood sugar level (a measure of average blood sugar over the past few months) is between 6.8% and 8.5% (confirm with trial site)

Who may not be able to join:

  • You have type 1 diabetes
  • You are currently being treated with insulin, sulfonylurea, or meglitinide (certain diabetes medications)
  • You take non-diabetes medications that affect blood sugar levels, such as steroids (corticosteroids)
  • Your BMI (a measure of body weight relative to height) is below 25, or below 23 if you identify as Asian
  • Your weight has changed by more than 5 pounds in the 3 months before joining the study
  • Your kidneys are not functioning above a certain level, based on a blood test result (confirm with trial site)
  • You are currently pregnant or planning to become pregnant soon
  • You are currently breastfeeding
  • You have anemia (low red blood cell levels), which can affect how your blood sugar is measured
  • Your diabetes medications or their doses have changed in the 3 months before joining the study
  • You have another medical condition that might make it hard to follow the study's requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 July 2025
Est. completion
1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Hemoglobin A1c

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov